JD Health International Inc. (the “Company”) published a notice regarding an Extraordinary General Meeting (EGM) scheduled for December 8, 2025, at 10:30 a.m. in Beijing. The meeting will be held at Building C, Campus 2, No. 20 Kechuang 11 Street, BDA, Beijing, China.
The agenda includes four ordinary resolutions covering framework agreements dated September 29, 2025, between the Company and JD.com: • 2026 Technology and Traffic Support Services Framework Agreement • 2026 JD Sales Framework Agreement • 2026 Marketing Services Framework Agreement • 2026 Supply Chain Solutions and Logistics Services Framework Agreement
These resolutions seek confirmation, approval, and authorization for transactions and annual caps for the three years ending December 31, 2028, as detailed in the Company’s circular dated November 13, 2025.
Shareholders entitled to attend and vote may appoint proxies, with voting conducted by poll in compliance with relevant listing rules. The register of members will be closed from December 3, 2025, to December 8, 2025, with transfers requiring submission to the Company’s share registrar by December 2, 2025. The poll results will be announced in accordance with Hong Kong listing regulations.